109 related articles for article (PubMed ID: 2423280)
21. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
Brooks B; Rees RC
Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
[TBL] [Abstract][Full Text] [Related]
22. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
[TBL] [Abstract][Full Text] [Related]
23. Non-specifically activated human peripheral blood mononuclear cells are cytotoxic for human keratinocytes in vitro.
Kalish RS
J Immunol; 1989 Jan; 142(1):74-80. PubMed ID: 2462592
[TBL] [Abstract][Full Text] [Related]
24. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
Gray JD; Torten M; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
[TBL] [Abstract][Full Text] [Related]
25. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
26. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
27. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
28. IFN-beta 2/IL-6 augments the activity of human natural killer cells.
Luger TA; Krutmann J; Kirnbauer R; Urbanski A; Schwarz T; Klappacher G; Köck A; Micksche M; Malejczyk J; Schauer E
J Immunol; 1989 Aug; 143(4):1206-9. PubMed ID: 2787359
[TBL] [Abstract][Full Text] [Related]
29. Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
Sulica A; Gherman M; Manciulea M; Galatiuc C; Herberman RB
Nat Immun Cell Growth Regul; 1989; 8(5):266-78. PubMed ID: 2480519
[TBL] [Abstract][Full Text] [Related]
30. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K
J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182
[TBL] [Abstract][Full Text] [Related]
31. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
32. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
Ujiie T
Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
[TBL] [Abstract][Full Text] [Related]
33. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
[TBL] [Abstract][Full Text] [Related]
35. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
36. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.
Aronson FR; Libby P; Brandon EP; Janicka MW; Mier JW
J Immunol; 1988 Jul; 141(1):158-63. PubMed ID: 3259966
[TBL] [Abstract][Full Text] [Related]
37. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.
Svedersky LP; Shepard HM; Spencer SA; Shalaby MR; Palladino MA
J Immunol; 1984 Aug; 133(2):714-8. PubMed ID: 6203975
[TBL] [Abstract][Full Text] [Related]
39. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
[No Abstract] [Full Text] [Related]
40. Danazol suppresses both spontaneous and activated human lymphocyte-mediated cytotoxicity.
Viganó P; Di Blasio AM; Busacca M; Sabbadini MG; Vignali M
Am J Reprod Immunol; 1992 Aug; 28(1):38-42. PubMed ID: 1418415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
